Ex Parte COCKS et al - Page 4



              Appeal No. 2002-0870                                                                  Page 4                
              Application No. 09/208,206                                                                                  
                     With respect to the guidance provided by the specification, the examiner does                        
              not appear to question the ability of one skilled in the art to follow the protocol disclosed               
              in the specification.  Nor, apparently, does the examiner appear to question whether                        
              that protocol would have enabled one skilled in the art to obtain naturally occurring                       
              polypeptides found in humans that have a 90% sequence identity to SEQ ID NO:2.  We                          
              accept, for the sake of argument, that it would be iterative and time consuming to                          
              identify naturally occurring polypeptides found in humans that have a 90% sequence                          
              identity to SEQ ID NO:2, but undue experimentation has little to do with the quantity of                    
              experimentation; it is much more a function of the amount of guidance or direction                          
              provided.  As explained in PPG Indus., Inc. v. Guardian Indus. Corp., 75 F.3d 1558,                         
              1564, 37 USPQ2d 1618, 1623 (Fed. Cir. 1996):                                                                
                     [T]he question of undue experimentation is a matter of degree.  The fact                             
                     that some experimentation is necessary does not preclude enablement;                                 
                     what is required is that the amount of experimentation “must not be unduly                           
                     extensive.”  Atlas Powder Co. v. E.I. DuPont de Nemours & Co., 750 F.2d                              
                     1569, 1576, 224 USPQ 409, 413 (Fed. Cir. 1984).  The Patent and                                      
                     Trademark Office Board of Appeals summarized the point well when it                                  
                     stated:                                                                                              
                            The test is not merely quantitative, since a considerable                                     
                            amount of experimentation is permissible, if it is merely                                     
                            routine, or if the specification in question provides a                                       
                            reasonable amount of guidance with respect to the direction                                   
                            in which the experimentation should proceed to enable the                                     
                            determination of how to practice a desired embodiment of                                      
                            the invention claimed.                                                                        
                     Ex parte Jackson, 217 USPQ 804, 807 (1982).                                                          
                     Further, to the extent the examiner requires the specification to “provide                           
              enablement for all naturally occurring polypeptides found in humans that have 90%                           
              sequence identity to SEQ ID NO:2” (Answer, page 3, emphasis added), we note that no                         
              authority has been cited in support of this requirement.  On the contrary, “appellants are                  




Page:  Previous  1  2  3  4  5  6  7  Next 

Last modified: November 3, 2007